Patents And Health Under Discussion At WIPO This Week: What Role For The UN IP Agency? 12/12/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment Patents are often involved in public health policy discussions, and are considered by some as playing a major role in the escalating prices of new medicines, creating access issues. The World Intellectual Property Organization committee on patent law this week is discussing the issue and is holding information sessions by the Medicines Patent Pool, World Health Organization, and the World Trade Organization.
WTO Ministerial: Challenging Start Despite Latin American Declaration For Multilateral Trade System 11/12/2017 by Monika Ermert for Intellectual Property Watch Leave a Comment According to delegates speaking at the first plenary of the 11th Ministerial Meeting of the World Trade Organization in Buenos Aires today, member states face the risk of leaving with no joint agreement at all. For the much-debated e-commerce file for example there are eight different and irreconcilable proposals, the South African Ambassador Xavier Charm, chairman of the General Council, reported during the Welcome Session Sunday evening.
Analysis: As Biosimilar Of Key Cancer Drug Spreads, Where Is The Price Reduction? 11/12/2017 by Tatum Anderson for Intellectual Property Watch 1 Comment The first biosimilar of the blockbuster breast cancer drug trastuzumab is being prepared for launch in United States, following a decision by the Food and Drug Administration (FDA) to approve it earlier this month. The product, Ogivri, has been created by a joint venture between US Mylan and Indian company Biocon.
WIPO Committee On Development and IP Agrees On Future Work, Keeps Several Issues Open 11/12/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment The World Intellectual Property Organization Committee on Development and Intellectual Property in its latest meeting agreed on a list of items to be discussed at its next session. No consensus was found on a potential biennial conference on IP and development, but discussions are set to continue. The committee also agreed to a suggestion to invite the team conducting an independent review on the implementation of the Development Agenda Recommendations to further explain some of their own recommendations.
Global Patents Soar Again As China Tops Patent, Trademark, Design Filings 06/12/2017 by Peter Kenny for Intellectual Property Watch Leave a Comment Innovators around the world filed 3.1 million patent applications in 2016, up 8.3 percent in a seventh straight yearly increase, WIPO’s annual World Intellectual Property Indicators (WIPI) report shows. The report, WIPO’s annual report, released at the United Nations in Geneva today, showed China topping patent, trademark and design filings in 2016.
New UNCTAD, GIZ Toolbox: How To Achieve Policy Coherence For Local Production And Access To Medicines 05/12/2017 by Guest contributor for Intellectual Property Watch Leave a Comment What do investment, trade, intellectual property, health financing, R&D, industrial and medicines regulation policy have in common? They are all important building blocks for the successful promotion of local pharmaceutical manufacturing. As more and more countries are looking into building their own pharmaceutical production capacities, they need to ensure strong policy coherence to be successful.
EU-MERCOSUR FTA Puts At Risk Access To Medicines In Brazil, New Impact Assessment Study Finds 01/12/2017 by Intellectual Property Watch 4 Comments The European Union (EU) is currently negotiating a free trade agreement (FTA) with the four founding members of Mercosur (Argentina, Brazil, Paraguay and Uruguay), which comprises a chapter on intellectual property rights (IPR). A new round of negotiations is taking place from November 29th to December 8th in Brussels[1]. Word is that they aim to announce the closure of the agreement at the next World Trade Organization (WTO) Ministerial Conference that will be held from 10-13 of December in Buenos Aires and the clock is ticking to close all the chapters before that. The authors have conducted a study that shows the adoption of the measures proposed by the EU could put the sustainability of access to health policies in Brazil at risk, as they could sharply increase public expenditures on medicines.
ARIPO Adopts Plant Variety Regulations, As Farmers Advocacy Groups Raise Concern 30/11/2017 by Hillary Muheebwa for Intellectual Property Watch Leave a Comment KAMPALA, Uganda — The Forty-first Session of the Administrative Council of African Regional Intellectual Property Organization (ARIPO) held this month adopted the Regulations for the Implementation of the Arusha Protocol for the Protection of New Varieties of Plants, amidst protest from civil society organisations and farmer representatives.
Expert Panel Recommends That The WHO Move Forward On Transparency And Delinkage 28/11/2017 by Guest contributor for Intellectual Property Watch Leave a Comment On Monday, 27 November, the WHO published the recommendations of the overall programme review of the global strategy and plan of action on public, health innovation and intellectual property (EB142/14). The expert panel provided 33 recommendations which included 17 forward looking”high-priority actions” including on transparency and delinkage, writes Thiru Balasubramaniam.
WIPO Development And IP Committee This Week: Agenda Includes Flexibilities, Tech Transfer, SDGs, Studies 27/11/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment Following a session in May hailed as the most positive in years, the World Intellectual Property Organization Committee on Development and Intellectual Property reconvenes this week. Among items to be discussed are a revised proposal by the African Group to convene a biennial international conference on IP and development, how to deal with the United Nations Sustainable Development Goals, and recommendations of an independent review of the implementation of the 2007 WIPO Development Agenda Recommendations.